chr2-85344666-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP6_Moderate
The NM_017750.4(RETSAT):c.1184G>A(p.Arg395Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000162 in 1,614,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_017750.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RETSAT | NM_017750.4 | c.1184G>A | p.Arg395Gln | missense_variant | 7/11 | ENST00000295802.9 | |
RETSAT | XM_047444828.1 | c.1184G>A | p.Arg395Gln | missense_variant | 7/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RETSAT | ENST00000295802.9 | c.1184G>A | p.Arg395Gln | missense_variant | 7/11 | 1 | NM_017750.4 | P1 | |
RETSAT | ENST00000429806.5 | c.701G>A | p.Arg234Gln | missense_variant, NMD_transcript_variant | 5/8 | 1 | |||
RETSAT | ENST00000449375.1 | c.551G>A | p.Arg184Gln | missense_variant | 4/8 | 5 | |||
RETSAT | ENST00000438611.4 | c.*326G>A | 3_prime_UTR_variant, NMD_transcript_variant | 3/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152196Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000159 AC: 40AN: 251422Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135896
GnomAD4 exome AF: 0.000155 AC: 226AN: 1461854Hom.: 0 Cov.: 34 AF XY: 0.000169 AC XY: 123AN XY: 727242
GnomAD4 genome AF: 0.000230 AC: 35AN: 152314Hom.: 0 Cov.: 33 AF XY: 0.000295 AC XY: 22AN XY: 74484
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at